The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

This publication has 100 references indexed in Scilit:

• Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
  Proceedings of the National Academy of Sciences, 2007
• A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes
  American Journal of Human Genetics, 2007
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivo
  Proceedings of the National Academy of Sciences, 2007
• Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment
  Annals of the Rheumatic Diseases, 2006
• Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury
  Biochemical and Biophysical Research Communications, 2006
• IL-32, a novel cytokine with a possible role in disease
  Annals of the Rheumatic Diseases, 2006
• Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism
  PLoS Medicine, 2006
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
  Nature, 2006
• Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
  Nature, 2003
• IL1HY1: A Novel Interleukin-1 Receptor Antagonist Gene
  Biochemical and Biophysical Research Communications, 1999